CEO: | Adrian Kinkaid |
Chairman: | Simon Gordon Douglas |
Chief Scientific Officer: | Richard John Buick |
Non-Executive Dir: | Colin Walsh, Matthew Baker |
Address: | Springbank Industrial Estate, 1 Springbank Rd, Dunmurry, Belfast, United Kingdom, BT17 0QL |
Website: | https://www.fusionantibodies.com/ |
Sector: | Health Care(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | GB00BDQZGK16 |
Currency | UK Pounds |
Share Price | 13.75p |
Change Today | -1.25p |
% Change | -8.33 % |
52 Week High | 18.75p |
52 Week Low | 4.00p |
Volume | 1,315,601 |
Shares Issued | 113.66m |
Market Cap | £15.63m |
Beta | 0.02 |
RiskGrade | 464 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
15:59 | 47,181 @ 13.38p |
16:29 | 9,260 @ 13.77p |
16:29 | 4 @ 13.77p |
16:29 | 39 @ 13.50p |
16:29 | 36,010 @ 13.89p |
Chair | Simon Gordon Douglas |
CEO | Adrian Kinkaid |
You are here: research